RESUMO
The prognosis of central retinal vein occlusion (CRVO) is generally poor. I report a case of a 67-year-old man with CRVO who underwent Kampo therapy. He ultimately continued to use Unsei-in for one year and 10 months, and he also continued to use Gorei-san for 9 months with no severe side effects. His visual acuity, which was LV: 0.02 (n. c.) before this therapy, has improved to LV: 0.2(0.3×S+0.75D_??_C-1.0DA×110°). Ocular neovascularization did not occur. These results suggest Kampo therapy is effective on CRVO.
RESUMO
The effectiveness of Kampo therapy for facial redness was studied in 20 cases of atopic dermatitis, using the Kampo extract Unsei-in (EK-57, etc.), which is known to have antiinflammatory and anti-allergic activities. Unsei-in was used without other Kampo extracts in 10 cases. Of these, marked improvement was observed in one case (10%) and improvement in two cases (20%), all of which improved within two weeks. Five cases did not respond to therapy, and the redness worsened in two cases. In ten other cases Unsei-in was used in conjunction with other Kampo extracts. Of these, improvement was observed in three cases (30%). Adverse reactions such as redness over the entire body (one case; 5%) and gastric pain (one case; 5%) were also observed. Despite these reactions, Unsei-in was shown to be useful in the treatment of facial redness associated with atopic dermititis.